Back to Search
Start Over
Ramucirumab approved for gastric cancer.
- Source :
-
Cancer discovery [Cancer Discov] 2014 Jul; Vol. 4 (7), pp. 752-3. Date of Electronic Publication: 2014 May 08. - Publication Year :
- 2014
-
Abstract
- Based on data from the key phase III REGARD trial, the FDA approved ramucirumab as second-line therapy for patients with advanced stomach cancer and gastroesophageal junction adenocarcinoma.<br /> (©2014 American Association for Cancer Research.)
Details
- Language :
- English
- ISSN :
- 2159-8290
- Volume :
- 4
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Cancer discovery
- Publication Type :
- Periodical
- Accession number :
- 25002597
- Full Text :
- https://doi.org/10.1158/2159-8290.CD-NB2014-069